No Data
Express News | Nanjing Vazyme Biotech Says Its Technology Research and Development, Daily Operations Are Proceeding Normally
Express News | Nanjing Vazyme Biotech Says General Manager of Life Sciences Division Nie Junwei Resigned on Personal Reasons
Is Nanjing Vazyme Biotech (SHSE:688105) A Risky Investment?
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Nuoyizan (688105.SH) released its performance for the first half of the year, with a net income of 16.1595 million yuan, turning losses into profits.
Nuoyi Zan (688105. SH) released its 2024 interim report, with revenue of 0.649 billion yuan, an increase of ...
Investors Don't See Light At End Of Nanjing Vazyme Biotech Co.,Ltd's (SHSE:688105) Tunnel And Push Stock Down 27%No Data
No Data
